Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062238
Company: GLAXOSMITHKLINE
Company: GLAXOSMITHKLINE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DYCILL | DICLOXACILLIN SODIUM | EQ 250MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
DYCILL | DICLOXACILLIN SODIUM | EQ 500MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/31/1979 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/20/1998 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/06/1996 | SUPPL-1 | Labeling |
Label is not available on this site. |